SAVIC Inc. Empowers Qnovate Inc. with SAP S/4HANA Public Cloud for Unleashing Digital Transformation
TAMPA, FLA., May 16, 2023 – (ACN Newswire) – SAVIC Inc., a leading implementation partner,…
News
Ampco-Pittsburgh Corporation (NYSE: AP) Announces First Quarter 2023 Results
Q1 2023 net income of $0.7 million, or $0.03/share Q1 2023 sales growth of 11%…
Enerpac Tool Group Elects Colleen M. Healy as New Director
MILWAUKEE–(BUSINESS WIRE)–Enerpac Tool Group Corp. (NYSE:EPAC) announced today that the Board of Directors is expanding…
New Castle Community Schools Taps PowerSchool to Support College, Career, and Life Readiness Program
Indiana school district selects PowerSchool Workforce Development Cloud to offer best-in-class college and career planning…
Sunlight Financial Reports First Quarter 2023 Results
– 1Q23 Funded Loan Volume of $627.4 Million – – 1Q23 Total Revenue of $20.6…
Healthy Extracts Reports First Quarter 2023 Results
LAS VEGAS, May 15, 2023 (GLOBE NEWSWIRE) — Healthy Extracts Inc. (OTCQB: HYEX), a leading…
Healthy Extracts Reports First Quarter 2023 Results
LAS VEGAS, May 15, 2023 (GLOBE NEWSWIRE) — Healthy Extracts Inc. (OTCQB: HYEX), a leading…
Bioventus Reschedules Reporting of First Quarter Fiscal Year 2023 Financial Results to After Market Close on May 16, 2023
DURHAM, N.C., May 15, 2023 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the…
Bioventus Reschedules Reporting of First Quarter Fiscal Year 2023 Financial Results to After Market Close on May 16, 2023
DURHAM, N.C., May 15, 2023 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the…
Acer Therapeutics Reports Q1 2023 Financial Results and Provides Corporate Update
U.S. OLPRUVA™ launch progressing ahead of schedule with drug-in-channel now anticipated in mid-June 2023 NEWTON,…
Acer Therapeutics Reports Q1 2023 Financial Results and Provides Corporate Update
U.S. OLPRUVA™ launch progressing ahead of schedule with drug-in-channel now anticipated in mid-June 2023 NEWTON,…
GT Biopharma Reports First Quarter 2023 Financial Results and Provides Corporate Update
Cash of approximately $19.9 million as of March 31, 2023, provides ample runway to fund…
GT Biopharma Reports First Quarter 2023 Financial Results and Provides Corporate Update
Cash of approximately $19.9 million as of March 31, 2023, provides ample runway to fund…
ProMIS Neurosciences Announces First Quarter 2023 Financial Results and Recent Highlights
Received FDA clearance for investigational new drug (IND) application for lead therapeutic candidate, PMN310, in…
ProMIS Neurosciences Announces First Quarter 2023 Financial Results and Recent Highlights
Received FDA clearance for investigational new drug (IND) application for lead therapeutic candidate, PMN310, in…
Bellerophon Provides Clinical Program Update and Reports First Quarter 2023 Financial Results
Last Patient Completed Blinded Treatment in REBUILD Phase 3 Trial for INOpulse®; Pivotal Top-line Data…
Bellerophon Provides Clinical Program Update and Reports First Quarter 2023 Financial Results
Last Patient Completed Blinded Treatment in REBUILD Phase 3 Trial for INOpulse®; Pivotal Top-line Data…
Adamis Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update
Management to host webcast/conference call today at 2:00 p.m. PT / 5:00 p.m. ET SAN…
Adamis Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update
Management to host webcast/conference call today at 2:00 p.m. PT / 5:00 p.m. ET SAN…
Vaccinex Reports First Quarter 2023 Financial Results and Provides Corporate Update
Significant YTD Progress in Neurology and Oncology Programs New financing of $5MM closed without warrants,…